
Industry-wide survey shows eTMF applications improve inspection readiness and seen as key to shortening development time.
Industry-wide survey shows eTMF applications improve inspection readiness and seen as key to shortening development time.
BBK Worldwide has appointed Toshio Mori to Managing Director of Operations, Japan. Mori will lead business development and help drive sales and marketing as well as establishing and growing the company’s new office based in Tokyo, Japan.
BBK Worldwide, a clinical trial marketing firm, announced My Research Mate, a live streaming video app platform developed to educate consumers about treatment options and available clinical research studies.
Parallel 6, mobile engagement and management solutions provider, and Sentrian™, a Remote Patient Intelligence company announced its technology partnership.
Medidata, a global provider of cloud-based solutions for clinical research in life sciences, announced that PROMETRIKA, LLC, a full-service clinical research organization.
Comprehend Systems, a clinical software solutions provider, announced the launch of Continuous Quality for ClinOps.
ArisGlobal, a provider of cloud solutions to life sciences companies, announced it has acquired Medsight Solutions, which includes its integrated risk management solution, Medsight Sapphire.
ERT, a global provider of patient safety and efficacy endpoint data collection, cloud analytics and workflow solutions, announced that MasterScope® 2, its comprehensive diagnostic platform for spirometry, electrocardiogram (ECG) and home monitoring, has been successfully implemented with 350 investigative sites.
ArisGlobal, a provider of cloud solutions to life sciences companies, announced agReporter a solution for users to correspond with drug manufacturers and get the latest medical advice.
Version 3.0 of the TMF Reference Model incorporates feedback from its extensive industry use to enhance content clarity.
New faces among the Pharma Industry rise the ranks.
New portal solution allows investigators to access, sign, and upload eTMF documents on site.
Double-blind randomized controlled trials of new drugs may fail to measure how a medication’s performance can vary based on patients' lifestyle choices, especially if patients change their habits because they are anticipating treatment, according to a new study published in Plos One.
Comprehensive behavioral and performance data on over 40,000 investigator sites
Participate sets a new standard for usability, integration, and cost effectiveness for electronic patient reported outcomes (ePRO).